NSE · CELLPOINT · Retail
Cell Point (India) Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹369 Cr with net profit ₹0 Cr — a 0.02% net margin, versus 0.69% the period before.
Shareholding
As of 2026-06-30
- Promoter73.06%
- Public26.94%
1,714 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.8× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #334 of 688 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,71,625 Cr | 103.62 | 3.78 | 3.66% | 4.59% |
| Avenue Supermarts Limited | ₹2,23,416 Cr | 71.68 | 8.56 | 11.94% | 4.2% |
| Trent Ltd. | ₹1,64,182 Cr | 85.72 | 21.1 | 24.4% | 8.62% |
| FSN E-Commerce Ventures Ltd. | ₹1,01,123 Cr | 304.31 | 60.95 | 19.49% | 2.85% |
| Aditya Infotech Limited | ₹50,682 Cr | 106.18 | 13.81 | 16.16% | 10.38% |
| Vishal Mega Mart Limited | ₹44,037 Cr | 48.96 | 5.58 | 11.37% | 6.45% |
| Premier Energies Limited | ₹40,402 Cr | 22.83 | 7.85 | 34.23% | 19.11% |
| Aegis Logistics Limited | ₹40,053 Cr | 30.06 | 6.01 | 20.01% | 14.99% |
| Redington Limited | ₹25,603 Cr | 12.76 | 2.38 | 18.62% | 1.31% |
| Honasa Consumer Limited | ₹15,206 Cr | 60.26 | 10.75 | 19.03% | 10.3% |
| Cell Point (India) Ltd.(this company) | ₹27 Cr | 488.33 | 0.37 | 0.09% | 1.92% |
AI analysis
AI-generated · google/gemini-2.5-flashCell Point (India) Ltd. is listed on the Indian markets with a market capitalization of Rs 28 Cr. The company's revenue for the most recent period was Rs 326.26 Cr. It reported an EPS of 0.03. The debt-to-equity ratio stands at 0.64. Promoter shareholding is 73.0595%, with public shareholding at 26.9405%.
Positives
- +Promoter shareholding is high at 73.0595% as of March 31, 2026.
- +Debt-to-equity ratio is 0.64, indicating moderate leverage.
Negatives
- −The profit margin is 0%, indicating no reported profit from sales.
- −Return on Capital Employed (ROCE) is 4.8954%, which is relatively low.
- −The number of shareholders has decreased from 3256 in June 2023 to 1749 in March 2026.
- −EPS decreased from 4.93 in March 2023 to 0.97 in March 2024.
Financial Performance
Cell Point (India) Ltd. reported revenue of Rs 326.2586 Cr for the year ending March 2025. This marks a relatively small increase from Rs 322.9049 Cr in March 2024. Net profit for March 2025 was Rs 2.2615 Cr, an increase from Rs 1.6933 Cr in March 2024. The company's EPS was 1.21 in March 2025, compared to 0.97 in the previous year.
Profitability & Returns
The company's Return on Equity (ROE) is 8.5%, while Return on Capital Employed (ROCE) is 4.8954%. The profit margin for the most recent period was 0%. EPS for the latest period stands at 0.03. The price-to-earnings ratio is 22.76, and the book value per share is 39.77.
Balance Sheet
Cell Point (India) Ltd. has a debt-to-equity ratio of 0.64. The book value per share is Rs 39.77. The company's market capitalization is Rs 28 Cr. No dividend yield information is available for the company.
Ownership & Pledges
Public shareholding stands at 26.9405%. There is no promoter pledging indicated in the available data. As of March 31, 2026, the company had 1749 shareholders.
Shareholding History
Promoter holding has consistently been 73.0595% since June 2023. Public shareholding has also remained at 26.9405% over the same period. The number of shareholders has decreased from 3256 in June 2023 to 1749 in March 2026.
Data as of — price: 2026-11-07 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.